ARCHIVES

Change In Method Of Counting Cancer Incidence Results In More Attributed To Work Hazards

This article is from The Cancer Letter archive.

Vol. 04 No. 40 | October 6, 1978

Download PDF Visit The Full Archive

Related Articles

FDA, Genentech Agree On Framework for Avastin Hearing June 28-29

April 8, 2011

In Brief: FDA’s Burlington Moves to Wyeth-Ayerst; NAS Award to Beckman; Genetics Online

February 5, 1999

Cervical Cancer Screening Can Be Done Later, Less Often

December 25, 2009

DCE Board Delays Decision On New Collaborative Groups In Chemoprevention

November 30, 1984

FDA Discloses Responses, Toxicities For Burzynski’s “Antineoplastons”

April 24, 1998

Piedmont, Mid-Atlantic Organizations Win Competition for NCI Support Of New Regional Cooperative Groups

April 16, 1982